Ajay K. Singh

发表

KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

A. Kliger, R. Foley, D. Goldfarb, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Strategies for preservation of ovarian and testicular function after immunosuppression.

Ajay K. Singh, E. Ginsburg, S. Pendse, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

S. Solomon, M. Pfeffer, J. McMurray, 2019, Diabetes, obesity & metabolism.

Safety of ferumoxytol in patients with anemia and CKD.

Ajay K. Singh, A. Kausz, J. Hertel, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease.

Ajay K. Singh, E. Knight, Julie Lin, 2003, Journal of the American Society of Nephrology : JASN.

CLINICAL DIAGNOSIS Acute kidney injury from acute phosphate nephropathy and diabetic nodular glomerulosclerosis

S. Waikar, Ajay K. Singh, H. Rennke, 2009 .

Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.

E. Bedrick, Ajay K. Singh, K. Servilla, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pro: The value of randomized controlled studies in dialysis methods.

Ajay K. Singh, Z. Twardowski, J. Kari, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evolving clinical profile of IL-1β, IL-10 and CTLA-4 gene in rheumatoid factor positive Caucasian population

S. Singh, Ajay K. Singh, Neelima Singh, 2011 .

De novo multifocal renal cell carcinoma in the renal allograft.

Ajay K. Singh, H. Rennke, S. Tullius, 2009, Kidney international.

Correction of anemia with epoetin alfa in chronic kidney disease.

Huiman Barnhart, H. Barnhart, Ajay K. Singh, 2006, The New England journal of medicine.

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

S. Solomon, M. Pfeffer, J. McMurray, 2017, American Journal of Nephrology.

Managing Anemia and Metabolic Bone Disease in Dialysis Patients

Ajay K. Singh, J. Kari, 2016 .

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.

H. Uno, M. Pfeffer, J. McMurray, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease

R. Califf, H. Barnhart, Ajay K. Singh, 2013, American Journal of Nephrology.

How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

Ajay K. Singh, 2013, Seminars in dialysis.

Modulation of Platelet Activation in Chronic Kidney Disease Patients on Erythropoiesis-Stimulating Agents

Ajay K. Singh, V. Bansal, Y. Farag, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

ESA treatment in dialysis patients: Where do we go now?

Ajay K. Singh, 2011 .

Is there a deleterious effect of erythropoietin in end-stage renal disease?

Ajay K. Singh, 2011, Kidney international.

Reducing ESA Dose: We Can, and We Should

Ajay K. Singh, 2010 .

Message to the FDA on ESAs: REMS is not enough, more studies are needed.

Ajay K. Singh, 2010, Clinical journal of the American Society of Nephrology : CJASN.

What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?

Ajay K. Singh, 2010, Current opinion in nephrology and hypertension.

Does TREAT give the boot to ESAs in the treatment of CKD anemia?

Ajay K. Singh, 2010, Journal of the American Society of Nephrology : JASN.

Debate: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed?

Ajay K. Singh, 2010, American Journal of Nephrology.

ESAs in dialysis patients: are you a hedgehog or a fox?

Ajay K. Singh, 2010, Journal of the American Society of Nephrology : JASN.

The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.

Ajay K. Singh, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Posttransplant anemia: the role of sirolimus.

Ajay K. Singh, S. Fishbane, A. Djamali, 2009, Kidney international.

Treatment of Anemia Associated with chronic Kidney Disease with Methoxy polyethylene Glycol- epoetin Beta

Ajay K. Singh, T. Patel, 2009 .

Erythropoietin, Anemia and Kidney Disease

Ajay K. Singh, S. Pendse, T. Patel, 2009 .

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.

Ajay K. Singh, N. Dahl, D. Coyne, 2008, Journal of the American Society of Nephrology : JASN.

The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?

Ajay K. Singh, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Editorial: The Optimal Hemoglobin in Dialysis Patients— A Critical Review

Ashutosh Kumar Singh, Ajay K. Singh, S. Fishbane, 2007, Seminars in dialysis.

Anemia of chronic kidney disease.

Ashutosh Kumar Singh, Ajay K. Singh, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Reducing versus discontinuing erythropoietin at high hemoglobin levels.

Ajay K. Singh, D. Weiner, D. Miskulin, 2007, Journal of the American Society of Nephrology : JASN.

The target hemoglobin level in patients on dialysis

Ajay K. Singh, 2007 .

Ferric Gluconate Yields Cost-Savings in Hemodialysis Patients with High Ferritin and Low TSAT: Results from the DRIVE Studies

L. Pizzi, D. Goldfarb, Ajay K. Singh, 2007 .

Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study.

Ajay K. Singh, A. Housawi, A. Al-Harbi, 2010, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

Prevalence of vitamin D deficiency in Saudi adults.

Ajay K. Singh, D. Mousa, A. Housawi, 2013, Saudi medical journal.

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Akshay S. Desai, S. Solomon, M. Pfeffer, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of renal transplantation on multiple hormone levels in patients of chronic kidney disease: A single center study

R. Kumar, Ajay K. Singh, V. Malhotra, 2014 .

Core Concepts in Dialysis and Continuous Therapies

Ajay K. Singh, C. Magee, J. Tucker, 2016 .

Role of vitamin D in chronic kidney disease.

Ajay K. Singh, T. Patel, 2009, Seminars in nephrology.

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease : Data from the TREAT trial

S. Solomon, J. McMurray, A. Levey, 2018 .

Serum Amyloid P Inhibits Fibrosis Through FcγR-Dependent Monocyte-Macrophage Regulation in Vivo

Ajay K. Singh, J. Duffield, A. Castano, 2009, Science Translational Medicine.

The Renal ConsultAnalgesic nephropathy

Ajay K. Singh, N. Vadivel, S. Trikudanathan, 2007 .

Endothelial Activation Markers in Anemic Non-Dialysis Chronic Kidney Disease Patients

Ajay K. Singh, J. Duffield, T. Patel, 2008, Nephron Clinical Practice.

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.

Ajay K. Singh, Hong Zhang, J. Lv, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

High Prevalence of CKD of Unknown Etiology in Uddanam, India

Ajay K. Singh, Devi Madhavi Bhimarasetty, Satyanarayana Rentala, 2018, Kidney international reports.

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

S. Solomon, M. Pfeffer, J. McMurray, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Outcomes of Renal Transplantation for Recipients With Lupus Nephritis: Analysis of the Organ Procurement and Transplantation Network Database

Ajay K. Singh, S. Takemoto, S. Bunnapradist, 2006, Transplantation.

Chronic Kidney Disease in the Arab World: A Call for Action

Ajay K. Singh, J. Kari, Y. Farag, 2012, Nephron Clinical Practice.

Prevalence of Hyperparathyroidism, Mineral and Bone Disorders in Children with Advanced Chronic Kidney Disease

Ajay K. Singh, J. Kari, Y. Farag, 2016, The Indian Journal of Pediatrics.

Endocrine Complications of Chronic Kidney Disease

Ajay K. Singh, J. Kari, A. Raed, 2015 .

Progressive Increase of Inflammatory Biomarkers in Chronic Kidney Disease and End-Stage Renal Disease

Ajay K. Singh, D. Hoppensteadt, J. Fareed, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

Ajay K. Singh, L. Gesualdo, S. Ledbetter, 2017, Kidney international reports.

A prospective evaluation of renal replacement therapy modality eligibility.

Ajay K. Singh, S. Soroka, J. Brouillette, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The nephrology quiz and questionnaire: 2006.

Ajay K. Singh, S. Adler, L. Hamm, 2007, Clinical journal of the American Society of Nephrology : CJASN.

International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE)

V. Jha, N. Pearce, Ajay K. Singh, 2017, BMC Nephrology.

Essential and Secondary Hypertension

Ajay K. Singh, 2012 .

Iron deficiency in non-dialysis chronic kidney disease.

Ajay K. Singh, S. Fishbane, 2009, Kidney international.

Acute coronary syndrome in ESRD patients.

Ajay K. Singh, D. Charytan, L. Riella, 2009, Kidney international.

Carcinoma of Prostate: Emerging Trends in Management

Ajay K. Singh, A. Saxena, R. Chopra, 2005 .

Does treatment with calcitriol improve survival in predialysis patients with chronic kidney disease?

Ajay K. Singh, T. Patel, 2008, Nature Clinical Practice Endocrinology &Metabolism.

Erythropoietic response and outcomes in kidney disease and type 2 diabetes.

H. Uno, S. Solomon, M. Pfeffer, 2010, The New England journal of medicine.

The International Society of Nephrology (ISN) and the American Nephrologists of Indian Origin (ANIO) Online Clinical Nephropathology Certificate (CNC) program.

Sudhir V. Shah, Ajay K. Singh, J. Feehally, 2016, Kidney international.

Lupus Nephritis: The Ghosts of Treatments Past, Present, and Future

Ajay K. Singh, 2009 .

The role of kidney biopsy in the management of lupus nephritis

Ajay K. Singh, H. Rennke, B. Mittal, 2005, Current opinion in nephrology and hypertension.

Diabetes, Anemia and CKD: Why TREAT?

Ajay K. Singh, 2010, Current diabetes reports.

Immunopathogenesis of lupus and lupus nephritis: recent insights

Ajay K. Singh, R. Kewalramani, 2002, Current opinion in nephrology and hypertension.

Role of immunoturbidimetric plasma fibrin D-dimer test in patients with coronary artery disease as well as ischemic heart disease in emergency medicine

S. Singh, Ajay K. Singh, Neelima Singh, 2011 .

Core Concepts in the Disorders of Fluid, Electrolytes and Acid-Base Balance

Ajay K. Singh, D. Mount, M. Sayegh, 2013 .

Pathogenesis and Management of Secondary Hyperparathyroidism

Ajay K. Singh, K. Polu, 2006 .

Predictors of renal replacement therapy and mortality in children with chronic kidney disease

Ajay K. Singh, J. Kari, Y. Farag, 2015, Saudi medical journal.

Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).

C. Yancy, Ajay K. Singh, 2006, The American journal of cardiology.

Cognitive function and all-cause mortality in maintenance hemodialysis patients.

David A. Drew, H. Tighiouart, Ajay K. Singh, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Study of nonenzymatic antioxidant and lipid peroxide levels in rheumatoid arthritis

Ajay K. Singh, Neelima Singh, P. Mishra, 2012 .

Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.

S. Solomon, J. McMurray, V. Jha, 2021, The New England journal of medicine.

Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.

S. Solomon, J. McMurray, V. Jha, 2021, The New England journal of medicine.

Anemia in chronic kidney disease: new advances.

Ajay K. Singh, T. Patel, 2010, Heart failure clinics.

Anemia of chronic kidney disease: CHOIR and the FDA

Ajay K. Singh, 2007, Nature Clinical Practice Nephrology.

Anaemia of CKD—the CHOIR study revisited y

H. Barnhart, Ajay K. Singh, L. Szczech, 2007 .

Textbook of nephro-endocrinology

Ajay K. Singh, G. Williams, 2009 .

Review: In diabetes, intensive and standard glycemic control do not differ for end-stage kidney disease or death

Ajay K. Singh, I. Dasgupta, 2017, Annals of Internal Medicine.

T-Piece Resuscitator or Self Inflating Bag for Positive Pressure Ventilation during Neonatal Resuscitation: A Randomized Controlled Trial

Ajay K. Singh, Suryalata Kookna, S. Pandit, 2019 .

Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients

Ajay K. Singh, S. Fishbane, P. Fanti, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

24-hour isotonic sodium choloride was better than 7-hour sodium bicarbonate for preventing CIN

Ajay K. Singh, J. Kari, 2012, Annals of Internal Medicine.

Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.

Ajay K. Singh, W. Suki, N. Dahl, 2007, Journal of the American Society of Nephrology : JASN.

Anaemia: Does the KDIGO guideline move the needle in CKD anaemia?

Ajay K. Singh, 2012, Nature Reviews Nephrology.

Does correction of anemia slow the progression of chronic kidney disease?

Ajay K. Singh, 2007, Nature Clinical Practice Nephrology.

Response to ‘Evaluating living kidney donor candidates with minor medical abnormalities’

Ajay K. Singh, N. Vadivel, 2007 .

Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease.

Ajay K. Singh, R. Provenzano, 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Multiparametric Cardiac Magnetic Resonance for Chronic Kidney Disease: Mapping the Footprints of a "Silent Killer"?

Ashutosh Kumar Singh, R. Kwong, Ajay K. Singh, 2020, JACC. Cardiovascular imaging.

Outcome of acute kidney injury in pediatric patients admitted to the intensive care unit.

Ajay K. Singh, J. Kari, M. Shalaby, 2014, Clinical nephrology.

Renal immunology and pathology.

Ajay K. Singh, 1999, Current opinion in nephrology and hypertension.

Role for the FAS antigen in lupus 5 Fas antigen

Ajay K. Singh, 2022 .

Rapidly Deteriorating Kidney Function in a Young Man Previously Diagnosed with Membranous Nephropathy

Ajay K. Singh, D. D'avila, C. Poli-de-Figueiredo, 2010, Nephron Clinical Practice.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2003. A 68-year-old woman with impaired renal function.

R. Colvin, Ajay K. Singh, 2003, The New England journal of medicine.

Frequency of and risk factors for poor cognitive performance in hemodialysis patients

David A. Drew, H. Tighiouart, Ajay K. Singh, 2013, Neurology.

A comparative study of antioxidant potential of low density lipoprotein in type 2 diabetic men and women

S. Singh, Ajay K. Singh, Neelima Singh, 2012, Indian journal of endocrinology and metabolism.

Bouveret's syndrome: appearance on CT and upper gastrointestinal radiography before and after stone obturation.

P. Sagar, Ajay K. Singh, A. Shirkhoda, 2003, AJR. American journal of roentgenology.

Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods.

Ajay K. Singh, Z. Twardowski, M. Misra, 2013, Nephrology, Dialysis and Transplantation.

Consanguinity in Saudi Arabia: a unique opportunity for pediatric kidney research.

Ajay K. Singh, R. Kleta, D. Bockenhauer, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR.

R. Califf, H. Barnhart, Ajay K. Singh, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Antiglomerular basement membrane disease associated with Castleman disease.

Ajay K. Singh, Hong Zhang, J. Lv, 2009, The American journal of the medical sciences.

60 – Neurological Manifestations of Renal Disease

Ajay K. Singh, R. Bhatia, 2007 .

Hemoglobin Control, ESA Resistance, and Regular Low‐Dose IV Iron Therapy: A Review of the Evidence

Ajay K. Singh, Ajay Singh, 2009, Seminars in dialysis.

A potential living kidney donor with prediabetes.

Ajay K. Singh, M. Pendergrass, C. Magee, 2009, Kidney international.

A 39-year-old pregnant woman with polyuria and

Ajay K. Singh, J. A. Rached, 2006 .

Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK (Screening and Early Evaluation of Kidney Disease) study

Ashutosh Kumar Singh, Jai Prakash, Sanjiv Jasuja, 2013, BMC Nephrology.

Collapsing Focal Segmental Glomerulosclerosis in a Young Child

Ajay K. Singh, J. Kari, Ghadeer A. Mokhtar, 2012, Nephron Clinical Practice.

New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI.

P. Kimmel, Ajay K. Singh, Samir S. Patel, 2002, Seminars in nephrology.

Hemoglobin target in chronic kidney disease: a pediatric perspective

Ajay K. Singh, S. Keithi-Reddy, 2009, Pediatric Nephrology.

Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa: The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience

H. Uno, S. Solomon, M. Pfeffer, 2011, Circulation.

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

S. Solomon, M. Pfeffer, J. McMurray, 2009, The New England journal of medicine.

Hypertension in the developing world: challenges and opportunities.

Ajay K. Singh, Bharati V Mittal, Ajay K Singh, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Response to ‘Characteristics of uremic pruritus in hemodialysis patients: data from a single center’

Ajay K. Singh, S. Keithi-Reddy, 2008 .

ASN clinicopathologic conference.

Ajay K. Singh, L. Racusen, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Core concepts in parenchymal kidney disease

Ajay K. Singh, F. Fervenza, Julie Lin, 2014 .

Inhibition of Cytokine Gene Expression by Sodium Salicylate in a Macrophage Cell Line through an NF-κB-Independent Mechanism

Ajay K. Singh, S. Lemay, T. Lebedeva, 1999, Clinical Diagnostic Laboratory Immunology.

Anemia and Disorders of Hemostasis in Chronic Kidney Disease

Ajay K. Singh, Joshua S. Hundert, 2014 .

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

R. Califf, H. Barnhart, Ajay K. Singh, 2008, Kidney international.

Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE)

A. Levin, G. Remuzzi, N. Pearce, 2019, BMJ Open.

Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study.

Ajay K. Singh, A. Ingsathit, A. Thakkinstian, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Kidney pathological changes in metabolic syndrome: a cross-sectional study.

Ajay K. Singh, H. Rennke, T. Patel, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

S. Solomon, M. Pfeffer, J. McMurray, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions.

Ajay K. Singh, T. Patel, 2009, Seminars in nephrology.

Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease.

Ajay K. Singh, M. Goligorsky, F. Addabbo, 2008, Kidney international.

Core concepts in renal transplantation

Ajay K. Singh, M. Sayegh, A. Chandraker, 2012 .

Renal pathology practice globally: identifying needs and meeting the challenge.

A. Levin, D. Harris, Ajay K. Singh, 2019, Kidney international.

Are we Treating or Curing Tuberculosis? Profile of Secondary Renal Amyloidosis in Patients Receiving Anti Tubercular Treatment

Ajay K. Singh, V. Malhotra, Rajesh Kumar, 2014 .

Cardiac transplantation and cyclosporine

S. Waikar, Ajay K. Singh, H. Rennke, 2007 .

BP in Dialysis: Results of a Pilot Study.

Mahboob Rahman, A. Levey, R. Kwong, 2017, Journal of the American Society of Nephrology : JASN.

Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study

Jai Prakash, Sanjiv Jasuja, Sham Sunder, 2014, BMC Nephrology.

Occupational risk factors for chronic kidney disease in Andhra Pradesh: ‘Uddanam Nephropathy’

Ajay K. Singh, V. A. Singh, R. Tatapudi, 2020, Renal failure.

Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.

S. Solomon, M. Pfeffer, J. McMurray, 2005, American heart journal.

Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes.

Ajay K. Singh, A. Agarwal, 2010, Heart failure clinics.

Therapy with Erythropoiesis- Agents and Renal and Nonrenal Outcomes

Ajay K. Singh, A. Agarwal, 2010 .

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Ajay K. Singh, J. Fink, M. Weir, 2017, American Journal of Nephrology.

Managing anemia in dialysis patients: hemoglobin cycling and overshoot.

Ajay K. Singh, E. Milford, S. Fishbane, 2008, Kidney international.

A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease

Ajay K. Singh, L. Wise, C. Vallarino, 2017, Therapeutic advances in drug safety.

Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro.

Ajay K. Singh, 2009, Journal of the American Society of Nephrology : JASN.

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

S. Solomon, J. McMurray, V. Jha, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.

Ajay K. Singh, G. McMahon, 2019, Current opinion in nephrology and hypertension.

Management of Anemia in Chronic Kidney Disease

Ajay K. Singh, Hilda E Fernandez, 2015 .

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.

R. Califf, H. Barnhart, G. Felker, 2010, Kidney international.

Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

H. Uno, S. Solomon, M. Pfeffer, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Anaemia of CKD--the CHOIR study revisited.

H. Barnhart, Ajay K. Singh, L. Szczech, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease.

Ajay K. Singh, S. Pendse, 2005, The Medical clinics of North America.

The FDA black box for EPO: what should nephrologists do?

Ajay K. Singh, 2007, Nephrology news & issues.

Route of Epoetin Administration Influences Hemoglobin Variability in Hemodialysis Patients

D. Reda, Ajay K. Singh, J. Kaufman, 2008, American Journal of Nephrology.

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

S. Solomon, J. McMurray, V. Jha, 2021, Nephrology, Dialysis and Transplantation.

Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.

R. Califf, H. Barnhart, Ajay K. Singh, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Rebuttal: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed?

Ajay K. Singh, 2010, American Journal of Nephrology.

Pure red cell aplasia due to follow-on epoetin.

Ajay K. Singh, S. Keithi-Reddy, S. Kandasamy, 2008, Kidney international.

Response to ‘Not all new recombinant human erythropoietins are biosimilars’

Ajay K. Singh, S. Keithi-Reddy, 2009 .

Core concepts in acute kidney injury

Ajay K. Singh, P. Murray, V. Patki, 2018, Springer US.

Acute phosphate nephropathy.

S. Waikar, Ajay K. Singh, H. Rennke, 2009, Kidney international.

New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences?

Shelley Hurwitz, Ajay K. Singh, H. Rennke, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Contents Vol. 31, 2010

R. Foley, Ajay K. Singh, F. Locatelli, 2010, American Journal of Nephrology.

Metabolic syndrome and chronic kidney disease

Ajay K. Singh, J. Kari, 2013, Current opinion in nephrology and hypertension.

Prevention of intravenous contrast-induced nephropathy in hospital inpatients.

D. Faxon, Ajay K. Singh, C. Binkert, 2008, Critical pathways in cardiology.

Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK ( Screening and Early Evaluation of Kidney

H. Ballal, Ajay K. Singh, V. Kher, 2013 .

Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.

Ajay K. Singh, R. Goldstein, A. Guidon, 2019, The New England journal of medicine.

Image-guided Percutane- ous Splenic Interventions 1

Ajay K. Singh, P. Hahn, A. Gervais, 2012 .

The Brigham Intensive Review of Internal Medicine

J. Loscalzo, Ajay K. Singh, 2017 .

Erythropoietic response and outcomes in kidney disease and type 2 diabetes.

H. Uno, S. Solomon, M. Pfeffer, 2010, The New England journal of medicine.

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

S. Solomon, M. Pfeffer, J. McMurray, 2009, The New England journal of medicine.

A prospective evaluation of renal replacement therapy modality eligibility.

Ajay K. Singh, S. Soroka, J. Brouillette, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease.

Ajay K. Singh, E. Knight, Julie Lin, 2003, Journal of the American Society of Nephrology : JASN.

Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa: The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience

H. Uno, S. Solomon, M. Pfeffer, 2011, Circulation.

Hemoglobin target in chronic kidney disease: a pediatric perspective

Ajay K. Singh, S. Keithi-Reddy, 2009, Pediatric Nephrology.

Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions.

Ajay K. Singh, T. Patel, 2009, Seminars in nephrology.

Interpreting results of clinical trials: a conceptual framework.

Ajay K. Singh, R. Agarwal, Ken Kelley, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Modulation of Platelet Activation in Chronic Kidney Disease Patients on Erythropoiesis-Stimulating Agents

Ajay K. Singh, V. Bansal, Y. Farag, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Core Concepts in the Disorders of Fluid, Electrolytes and Acid-Base Balance

Ajay K. Singh, D. Mount, M. Sayegh, 2013 .